Search results
Results from the WOW.Com Content Network
The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture capital partners, including Celgene, General Electric Ventures, and Eli Lilly, committed a minimum of US$100 million to help launch 15 to 20 ventures in life sciences and biotechnology in 2014, [6] and in January 2018, the City of New ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
AMRI’s Allegra patent applications, from 1995, and the resulting patents were licensed to what is now Sanofi-Aventis. The company continues to receive royalties on the sale of Allegra and Telfast products globally. [23] In June 2014, AMRI acquired OsoBio Pharmaceuticals, a contract manufacturer specializing in aseptic filling, for $110 ...
388 Greenwich Street, originally called the Shearson Lehman Plaza and more recently the Travelers Building, is an office skyscraper in the Tribeca neighborhood of Lower Manhattan in New York City. The building is located at Greenwich Street , with frontages on North Moore and West Streets. 388 Greenwich Street forms a complex with the ...
Global Pharma Healthcare, the manufacturer of eyedrops recently linked to deaths and injuries, lacked measures to assure sterility at its factory in India, according to a preliminary report ...
In 1994, Bayer reacquired full rights to all former Bayer products [8] after they purchased the Winthrop division of over-the-counter drugs from GlaxoSmithKline, and the Miles name was discontinued. In 2012, Bayer relocated the top United States administrative head to the Bayer HealthCare site in Whippany .
General Atlantic backed Royalty Pharma ahead of the company's 2020 IPO, which was among the largest U.S. IPOs that year and was the second-largest pharmaceutical listing ever. [21] The firm also expanded its footprint in Asia in 2020 with an $870 million investment in India's digital services platform Jio Platforms .
The Endo Pharmaceuticals Building, also known as "Endo Laboratories", is a pharmaceutical plant designed by architect Paul Rudolph in 1962 in Garden City, New York, in the receding farmlands of Long Island. The "castle-like structure" was built to house the Endo Pharmaceuticals research, manufacturing and administration facilities.